The Best of the AUA 2002: Basic science

Presented by Ralph Buttyan, PhD, Columbia-Presbyterian MedicalCenter, New York.

Related Content:

Drug Therapy

Nedosiran explored in primary hyperoxaluria type 3

Enrollment completed in pivotal trial of nedosiran for hyperoxaluria

FDA approves androgen inhibitor for metastatic PCa